118 related articles for article (PubMed ID: 2991738)
1. Molecular structure of Ro15-1788 and a model for the binding of benzodiazepine receptor ligands. Structural identification of common features in antagonists.
Codding PW; Muir AK
Mol Pharmacol; 1985 Aug; 28(2):178-84. PubMed ID: 2991738
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology of the human gamma-aminobutyric acidA receptor alpha 4 subunit expressed in Xenopus laevis oocytes.
Whittemore ER; Yang W; Drewe JA; Woodward RM
Mol Pharmacol; 1996 Nov; 50(5):1364-75. PubMed ID: 8913369
[TBL] [Abstract][Full Text] [Related]
3. Stereochemical features controlling binding and intrinsic activity properties of benzodiazepine-receptor ligands.
Borea PA; Gilli G; Bertolasi V; Ferretti V
Mol Pharmacol; 1987 Apr; 31(4):334-44. PubMed ID: 3033465
[TBL] [Abstract][Full Text] [Related]
4. Quantitative structure-activity relationship study of some benzodiazepine-receptor ligands having inverse agonist/antagonist and agonist actions.
Sharma RC; Ojha TN; Tiwari S; Singh P
Drug Des Discov; 1992; 9(2):135-43. PubMed ID: 1338366
[TBL] [Abstract][Full Text] [Related]
5. Biphasic actions of the benzodiazepine receptor inverse agonist RU34347 in the rat cerebellar slice.
Pringle AK; Gardner CR; Walker RJ
Brain Res; 1996 Apr; 715(1-2):155-62. PubMed ID: 8739634
[TBL] [Abstract][Full Text] [Related]
6. Model structures of the N-methyl-D-aspartate receptor subunit NR1 explain the molecular recognition of agonist and antagonist ligands.
Moretti L; Pentikäinen OT; Settimo L; Johnson MS
J Struct Biol; 2004 Mar; 145(3):205-15. PubMed ID: 14960371
[TBL] [Abstract][Full Text] [Related]
7. Bidirectional effects of benzodiazepine binding site ligands in the passive avoidance task: differential antagonism by flumazenil and beta-CCt.
Savić MM; Obradović DI; Ugresić ND; Cook JM; Yin W; Bokonjić DR
Behav Brain Res; 2005 Mar; 158(2):293-300. PubMed ID: 15698896
[TBL] [Abstract][Full Text] [Related]
8. The multiplicity of actions of benzodiazepine receptor ligands.
Haefely WE; Martin JR; Richards JG; Schoch P
Can J Psychiatry; 1993 Nov; 38 Suppl 4():S102-8. PubMed ID: 8306240
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockers.
Campiani G; Fiorini I; De Filippis MP; Ciani SM; Garofalo A; Nacci V; Giorgi G; Sega A; Botta M; Chiarini A; Budriesi R; Bruni G; Romeo MR; Manzoni C; Mennini T
J Med Chem; 1996 Jul; 39(15):2922-38. PubMed ID: 8709127
[TBL] [Abstract][Full Text] [Related]
10. A three-dimensional model of the delta-opioid pharmacophore: comparative molecular modeling of peptide and nonpeptide ligands.
Shenderovich MD; Liao S; Qian X; Hruby VJ
Biopolymers; 2000 Jun; 53(7):565-80. PubMed ID: 10766952
[TBL] [Abstract][Full Text] [Related]
11. In vitro characterization of benzodiazepine receptor agonists, antagonists, inverse agonists and agonist/antagonists.
Wood PL; Loo P; Braunwalder A; Yokoyama N; Cheney DL
J Pharmacol Exp Ther; 1984 Dec; 231(3):572-6. PubMed ID: 6094792
[TBL] [Abstract][Full Text] [Related]
12. Development of a comprehensive pharmacophore model for the benzodiazepine receptor.
Zhang W; Koehler KF; Zhang P; Cook JM
Drug Des Discov; 1995 Jan; 12(3):193-248. PubMed ID: 7662830
[TBL] [Abstract][Full Text] [Related]
13. [The benzodiazepine receptor: the enigma of the endogenous ligand].
Pélissolo A
Encephale; 1995; 21(2):133-40. PubMed ID: 7781584
[TBL] [Abstract][Full Text] [Related]
14. Behavioral and biochemical characterization of benzodiazepine receptor partial agonists in pigeons.
Witkin JM; Acri JB; Wong G; Gleeson S; Barrett JE
J Pharmacol Exp Ther; 1996 Apr; 277(1):87-96. PubMed ID: 8613971
[TBL] [Abstract][Full Text] [Related]
15. Three-dimensional models of histamine H3 receptor antagonist complexes and their pharmacophore.
Axe FU; Bembenek SD; Szalma S
J Mol Graph Model; 2006 May; 24(6):456-64. PubMed ID: 16386444
[TBL] [Abstract][Full Text] [Related]
16. Do the intrinsic actions of benzodiazepine receptor antagonists imply the existence of an endogenous ligand for benzodiazepine receptors?
File SE; Pellow S
Adv Biochem Psychopharmacol; 1986; 41():187-202. PubMed ID: 3017069
[No Abstract] [Full Text] [Related]
17. Regional difference in brain benzodiazepine receptor carbohydrates.
Sweetnam PM; Tallman JF
Mol Pharmacol; 1986 Mar; 29(3):299-306. PubMed ID: 3005837
[TBL] [Abstract][Full Text] [Related]
18. Benzodiazepine receptors: differential ligand interactions and purification of the receptor protein.
Möhler H
Adv Biochem Psychopharmacol; 1983; 38():47-56. PubMed ID: 6142607
[TBL] [Abstract][Full Text] [Related]
19. Apparent pA2 values of benzodiazepine antagonists and partial agonists in monkeys.
Paronis CA; Bergman J
J Pharmacol Exp Ther; 1999 Sep; 290(3):1222-9. PubMed ID: 10454498
[TBL] [Abstract][Full Text] [Related]
20. Functional comparison of the role of gamma subunits in recombinant human gamma-aminobutyric acidA/benzodiazepine receptors.
Wafford KA; Bain CJ; Whiting PJ; Kemp JA
Mol Pharmacol; 1993 Aug; 44(2):437-42. PubMed ID: 8102787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
